EQT Logo
Current Portfolio

AviadoBio

AviadoBio is developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

Key Facts
Sector

Healthcare

Country

United Kingdom

Fund

LSP Dementia Fund

Entry

2021

Website

Aviadobio

A doctor in a white coat holding up a series of brain MRI scans, with a stethoscope around their neck.

Founded in 2003 and headquartered in Lehi, Utah, Avetta’s innovative SaaS platform enables customers to mitigate supply chain risk complexity by managing supplier risk factors across health, safety and sustainability, among other risk vectors. The two-sided network of clients and suppliers facilitates contractor prequalification and worker competency management at scale across major industries globally, resulting in reduced accident levels, improved compliance rates, higher levels of operational, sustainability, and ethical excellence, and increased supplier eligibility for jobs.

Market trends and drivers

Global supply chains face increasing complexity from globalization and digitization, as well as heightened safety, compliance and sustainability requirements. Backed by decades of innovation and established global scale across industries, Avetta helps companies mitigate this complexity and drive sustainable resilience for clients and suppliers.

Investment potential

EQT will support Avetta in its growth and innovation journey through the development of new products and technologies that enhance the value proposition for both hiring clients and suppliers, adoption of AI / automation, and global expansion to make global supply chains more resilient, safe, and sustainable.

Board of directors

Chairperson

Scott Stephenson

Board member

Shanti Atkins

Board member

Arvindh Kumar

Board member

Tyler Parker

Management

CEO

Arshad Matin

CFO

Brandon Grinwis

Do You Want to Know More?

We are eager to explore how we can achieve great things together.